Pharmaceuticals
Healthcare Startup One BioMed closes US$5M Series A Funding Round
SINGAPORE, July 10, 2019 /PRNewswire/ -- One BioMed Pte Ltd, a Singapore-based medical diagnostics company, announced today that it has closed aUS$5 million Series A financing round, led bySingapore-based Biopath Ventures and US-based ARCH Venture Partners, with Enterprise Singapore's investment ...
Hummingbird Bioscience Closes Extended Series A Financing To Advance Clinical Pipeline
SINGAPORE, July 10, 2019 /PRNewswire/ -- Hummingbird Bioscience, a Singapore founded biotech company focused on the discovery and development of novel antibody-based therapeutics, today announced the successful completion of an extended Series A financing round. The round was led by Heritas Capit...
ISTH Announces Launch Of New Global Education Initiative In Gene Therapy For Hemophilia
MELBOURNE, Australia, July 6, 2019 /PRNewswire/ -- The International Society on Thrombosis and Haemostasis (ISTH) is pleased to announce the official launch ofGene Therapy in Hemophilia: An ISTH Education Initiative. This landmark launch, the first of its kind in hemophilia, will take place duri...
NeuroVive Initiates Second Part of its Ongoing KL1333 Phase Ia/b Clinical Study
LUND, Sweden, 4 July 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) today announced that the company has initiated the second part in its ongoing Phase Ia/b clinical study with KL1333, NeuroVive's candidate drug for chronic treatment of genetic mitochondri...
Gilead Sciences Announces Launch of Asia Pacific Rainbow Grant 2019
HONG KONG, July 3, 2019 /PRNewswire/ -- Gilead Sciences, Inc. today announced the launch of the 2019 Gilead Asia Pacific Rainbow Grant program, a grant initiative that supports community-led programs for people living with HIV in theAsia Pacific region. Non-governmental or advocacy organizations ...
A2A Pharmaceuticals Appoints Dr. Sotirios Stergiopoulos Chief Executive Officer
NEW YORK, July 3, 2019 /PRNewswire/ -- A2A Pharmaceuticals Inc. (A2A), a biotechnology company committed to the advancement of innovative scientific research and new therapeutic agents, today announced the appointment of Dr. Sotirios G. Stergiopoulos as President and Chief Executive Officer. He ha...
Asieris and Photocure Enter into a License Agreement for World-Wide Development and Commercialization of Cevira®
SHANGHAI and OSLO, Norway, July 2, 2019 /PRNewswire/ -- Asieris MediTech Co, Ltd (Asieris), aChina-based biotech company specializing in the development and commercialization of new drugs for the treatment of genitourinary tumors and related diseases, and Photocure ASA (Photocure, PHO: OSE), The ...
Dachser India receives IATA CEIV Pharma certification
MUMBAI, India, July 2, 2019 /PRNewswire/ -- The International Airport Transport Association (IATA) recently awarded theMumbai and Hyderabad branches of Dachser India with the prestigious CEIV Pharma certification, recognizing the company for its excellence in transporting Life Science and Healthc...
CSL Behring Delivers on its Promise to Advance Bleeding Disorder Treatment Research by Supporting 16 Data Presentations at ISTH 2019
Novel real world evidence for AFSTYLA® and IDELVION® to be highlighted MELBOURNE, Australia, July 2, 2019 /PRNewswire/ -- Global biotherapeutics leaderCSL Behring announced today that the company will support the presentation of new data from its recombinant coagulation factor programs at this ...
Inaugural Winner of the Mundipharma Cancer Care Challenge Shines at Innovfest Unbound
SINGAPORE, June 28, 2019 /PRNewswire/ -- The five finalist teams of the inaugural 'Mundipharma Cancer Care Challenge' pitched their ideas on how to harness the power of technology to improve the lives of cancer patients to a panel of judges atSoutheast Asia's largest innovation festival, Innovfes...
Johnson & Johnson Innovation Opens JLABS @ Shanghai in Collaboration with Shanghai Pharma Engine Company Ltd.
SHANGHAI, June 27, 2019 /PRNewswire/ -- Johnson & Johnson Innovation, Division of Johnson & Johnson (China) Investment Ltd., today announced the opening of JLABS @Shanghai, the world's largest JLABS and the first in Asia Pacific. The 4,400-square-meter facility, located inShanghai's Zhangjiang...
Yisheng Biopharma Receives IND Clearance from China NMPA to Initiate Clinical Trial of YS-ON-001 in the Treatment of Advanced Solid Tumors
BEIJING, June 27, 2019 /PRNewswire/ -- Yisheng Biopharma Co., Ltd. ("Yisheng Biopharma"), a biopharmaceutical company focusing on research, development, manufacturing, sales and marketing of immunological biologics and vaccines, announced that it has received Investigational New Drug (IND) cleara...
Inovio Completes Enrollment of VGX-3100 Phase 3 Trial (REVEAL 1) for the Treatment of HPV-Related Cervical Pre-cancer
PLYMOUTH MEETING, Pennsylvania, June 26, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced the completion of target enrollment of 198 participants for its pivotal Phase 3 registration trial ("REVEAL 1") of VGX-3100, a novel DNA-based immunotherapy being tested to tre...
Week's Top Stories
Most Reposted
Another 'Reason to Travel': Agoda and Singapore Tourism Board Renew Partnership to Boost Travel to Singapore
[Picked up by 350 media titles]
2024-06-19 11:00MIFB 2024 ENLISTS F&B EXPERTS TO SPEAK ON THE LATEST IN INDUSTRY TRENDS AND THE FUTURE OF FOOD
[Picked up by 335 media titles]
2024-06-20 16:24New Study Finds Cybersecurity as Top Concern Among Automotive Manufacturers
[Picked up by 317 media titles]
2024-06-19 08:05k-ID Closes $45 Million Series A from Andreessen Horowitz and Lightspeed Venture Partners to Set a New Global Benchmark for Age-appropriate Gaming Experiences
[Picked up by 317 media titles]
2024-06-25 21:00THEIR ROYAL HIGHNESSES THE DUKE AND DUCHESS OF EDINBURGH CELEBRATE THE GRAND OPENING OF THE PENINSULA LONDON, BELGRAVIA
[Picked up by 313 media titles]
2024-06-19 11:38